Serial laboratory investigations and special investigations to rule out specific causes of polycythaemia
| Blood . | Date . | |||||
|---|---|---|---|---|---|---|
| 1 February 2021 . | 10 March 2021 . | 25 March 2021 . | 18 April 2021 . | 3 May 2021 . | 24 May 2021 . | |
| Hb (g/L)(130–180) | 208 | 189 | 189 | 180 | 170 | |
| HCT (L/L)(0.40–0.54) | 0.60 | 0.56 | 0.56 | 0.51 | 0.49 | |
| Platelets (×109/L)(150–400) | 275 | 248 | 184 | 163 | 189 | |
| WCC (×109/L)(4.0–11.0) | 9.9 | 9.6 | 7.1 | 5.4 | 6.8 | |
| Eosinophils (×109/L)(<0.4) | 0.6 | 0.4 | 0.7 | 0.9 | 0.9 | |
| LH (IU/L)(0.6–12.0) | <0.1 | 0.2 | 1.3 | |||
| FSH (IU/L)(1.0–12.0) | 0.2 | 1.2 | 1.9 | |||
| Free-testosterone (pmol/L)(270–864) | 1106 | 115 | 295 | |||
| Testosterone (nmol/L)(8.0–30.0) | 46.4 | 6.7 | 16.5 | |||
| Serum erythropoietin (U/L)(2.6–18.5) | 22.2 | |||||
| JAK2 mutation | Not detected | |||||
| Selenium (umol/L)(0.6–1.9) | 1.2 | |||||
| Zinc (umol/L)(10.7–25.0) | 12.9 | |||||
| Cholesterol mmol/L (<5.5) | 6.4 | |||||
| Triglycerides (mmol/L)(<1.7) | 2.0 | |||||
| HDL-cholesterol (mmol/L) (>1.00) | 1.10 | |||||
| LDL-cholesterol (mmol/L)(<3.5) | 4.4 | |||||
| LDL/HDL ratio (<3.5) | 4.0 | |||||
| Cholesterol/HDL ratio (<4.5) | 5.8 | |||||
| Troponin (ng/L) (<26) | 19 | |||||
| Blood . | Date . | |||||
|---|---|---|---|---|---|---|
| 1 February 2021 . | 10 March 2021 . | 25 March 2021 . | 18 April 2021 . | 3 May 2021 . | 24 May 2021 . | |
| Hb (g/L)(130–180) | 208 | 189 | 189 | 180 | 170 | |
| HCT (L/L)(0.40–0.54) | 0.60 | 0.56 | 0.56 | 0.51 | 0.49 | |
| Platelets (×109/L)(150–400) | 275 | 248 | 184 | 163 | 189 | |
| WCC (×109/L)(4.0–11.0) | 9.9 | 9.6 | 7.1 | 5.4 | 6.8 | |
| Eosinophils (×109/L)(<0.4) | 0.6 | 0.4 | 0.7 | 0.9 | 0.9 | |
| LH (IU/L)(0.6–12.0) | <0.1 | 0.2 | 1.3 | |||
| FSH (IU/L)(1.0–12.0) | 0.2 | 1.2 | 1.9 | |||
| Free-testosterone (pmol/L)(270–864) | 1106 | 115 | 295 | |||
| Testosterone (nmol/L)(8.0–30.0) | 46.4 | 6.7 | 16.5 | |||
| Serum erythropoietin (U/L)(2.6–18.5) | 22.2 | |||||
| JAK2 mutation | Not detected | |||||
| Selenium (umol/L)(0.6–1.9) | 1.2 | |||||
| Zinc (umol/L)(10.7–25.0) | 12.9 | |||||
| Cholesterol mmol/L (<5.5) | 6.4 | |||||
| Triglycerides (mmol/L)(<1.7) | 2.0 | |||||
| HDL-cholesterol (mmol/L) (>1.00) | 1.10 | |||||
| LDL-cholesterol (mmol/L)(<3.5) | 4.4 | |||||
| LDL/HDL ratio (<3.5) | 4.0 | |||||
| Cholesterol/HDL ratio (<4.5) | 5.8 | |||||
| Troponin (ng/L) (<26) | 19 | |||||
Hb, haemoglobin; HCT, haematocrit; WCC, white cell count; LH, luteinizing hormone; FSH, follicle-stimulating hormone; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Serial laboratory investigations and special investigations to rule out specific causes of polycythaemia
| Blood . | Date . | |||||
|---|---|---|---|---|---|---|
| 1 February 2021 . | 10 March 2021 . | 25 March 2021 . | 18 April 2021 . | 3 May 2021 . | 24 May 2021 . | |
| Hb (g/L)(130–180) | 208 | 189 | 189 | 180 | 170 | |
| HCT (L/L)(0.40–0.54) | 0.60 | 0.56 | 0.56 | 0.51 | 0.49 | |
| Platelets (×109/L)(150–400) | 275 | 248 | 184 | 163 | 189 | |
| WCC (×109/L)(4.0–11.0) | 9.9 | 9.6 | 7.1 | 5.4 | 6.8 | |
| Eosinophils (×109/L)(<0.4) | 0.6 | 0.4 | 0.7 | 0.9 | 0.9 | |
| LH (IU/L)(0.6–12.0) | <0.1 | 0.2 | 1.3 | |||
| FSH (IU/L)(1.0–12.0) | 0.2 | 1.2 | 1.9 | |||
| Free-testosterone (pmol/L)(270–864) | 1106 | 115 | 295 | |||
| Testosterone (nmol/L)(8.0–30.0) | 46.4 | 6.7 | 16.5 | |||
| Serum erythropoietin (U/L)(2.6–18.5) | 22.2 | |||||
| JAK2 mutation | Not detected | |||||
| Selenium (umol/L)(0.6–1.9) | 1.2 | |||||
| Zinc (umol/L)(10.7–25.0) | 12.9 | |||||
| Cholesterol mmol/L (<5.5) | 6.4 | |||||
| Triglycerides (mmol/L)(<1.7) | 2.0 | |||||
| HDL-cholesterol (mmol/L) (>1.00) | 1.10 | |||||
| LDL-cholesterol (mmol/L)(<3.5) | 4.4 | |||||
| LDL/HDL ratio (<3.5) | 4.0 | |||||
| Cholesterol/HDL ratio (<4.5) | 5.8 | |||||
| Troponin (ng/L) (<26) | 19 | |||||
| Blood . | Date . | |||||
|---|---|---|---|---|---|---|
| 1 February 2021 . | 10 March 2021 . | 25 March 2021 . | 18 April 2021 . | 3 May 2021 . | 24 May 2021 . | |
| Hb (g/L)(130–180) | 208 | 189 | 189 | 180 | 170 | |
| HCT (L/L)(0.40–0.54) | 0.60 | 0.56 | 0.56 | 0.51 | 0.49 | |
| Platelets (×109/L)(150–400) | 275 | 248 | 184 | 163 | 189 | |
| WCC (×109/L)(4.0–11.0) | 9.9 | 9.6 | 7.1 | 5.4 | 6.8 | |
| Eosinophils (×109/L)(<0.4) | 0.6 | 0.4 | 0.7 | 0.9 | 0.9 | |
| LH (IU/L)(0.6–12.0) | <0.1 | 0.2 | 1.3 | |||
| FSH (IU/L)(1.0–12.0) | 0.2 | 1.2 | 1.9 | |||
| Free-testosterone (pmol/L)(270–864) | 1106 | 115 | 295 | |||
| Testosterone (nmol/L)(8.0–30.0) | 46.4 | 6.7 | 16.5 | |||
| Serum erythropoietin (U/L)(2.6–18.5) | 22.2 | |||||
| JAK2 mutation | Not detected | |||||
| Selenium (umol/L)(0.6–1.9) | 1.2 | |||||
| Zinc (umol/L)(10.7–25.0) | 12.9 | |||||
| Cholesterol mmol/L (<5.5) | 6.4 | |||||
| Triglycerides (mmol/L)(<1.7) | 2.0 | |||||
| HDL-cholesterol (mmol/L) (>1.00) | 1.10 | |||||
| LDL-cholesterol (mmol/L)(<3.5) | 4.4 | |||||
| LDL/HDL ratio (<3.5) | 4.0 | |||||
| Cholesterol/HDL ratio (<4.5) | 5.8 | |||||
| Troponin (ng/L) (<26) | 19 | |||||
Hb, haemoglobin; HCT, haematocrit; WCC, white cell count; LH, luteinizing hormone; FSH, follicle-stimulating hormone; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
